• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Depression Drug Rejected by FDA - Stock Tumbles

anonymous

Guest
The Food and Drug Administration rejected the company's application for approval of an experimental depression treatment, saying it had not shown sufficient proof of effectiveness. Alkermes said it disagreed with the FDA and would appeal the ruling.